Education
About Us
Working with TipRanks
Follow Us
Genprex Inc (GNPX)
NASDAQ:GNPX
GNPX Stock Chart & Stats
$2.84
-$0.08(-9.71%)
At close: 4:00 PM EST
$2.84
-$0.08(-9.71%)
Day’s Range― - ―
52-Week Range$2.61 - $63.00
Previous Close$0.82
Volume416.42K
Average Volume (3M)45.83M
Market Cap
$7.67M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.35
Shares Outstanding1,631,841
10 Day Avg. Volume111,389,673
30 Day Avg. Volume45,833,100
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.11
Price to Sales (P/S)0.00
P/FCF Ratio-0.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genprex News
GNPX FAQ
What was Genprex Inc’s price range in the past 12 months?
Genprex Inc lowest stock price was $2.61 and its highest was $63.00 in the past 12 months.
What is Genprex Inc’s market cap?
Genprex Inc’s market cap is $7.67M.
When is Genprex Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genprex Inc’s earnings last quarter?
Currently, no data Available
Is Genprex Inc overvalued?
According to Wall Street analysts Genprex Inc’s price is currently Overvalued.
Does Genprex Inc pay dividends?
Genprex Inc does not currently pay dividends.
What is Genprex Inc’s EPS estimate?
Genprex Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genprex Inc have?
Genprex Inc has 1,631,841 shares outstanding.
What happened to Genprex Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genprex Inc?
Currently, no hedge funds are holding shares in GNPX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genprex Inc
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Technical Analysis
Kazia Therapeutics
―
Galecto
―
Sensei Biotherapeutics
―
Bolt Biotherapeutics
―
Intensity Therapeutics, Inc.
―
Ownership Overview
3.87% Insiders
8.65% Mutual Funds
― Other Institutional Investors
72.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---